Government and Drug Makers Face with Seven Lawsuits over PPA Incident

The pharmaceutical industry is making a close observation on the on-going litigation process involving last year's ban on the production and sale of cold remedies containing phenylpropanolamine (PPA), which led to subsequent lawsuits filed by the public against the government and the manufacturers.

According to the Korea Food and Drug Administration (KFDA), currently there are seven legal pr...